Avinger Current Deferred Revenue Over Time
| AVGR Stock | USD 0.84 0.01 1.20% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Avinger Performance and Avinger Correlation. Avinger |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avinger. If investors know Avinger will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avinger listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.76) | Revenue Per Share 3.876 | Quarterly Revenue Growth (0.1) | Return On Assets (0.65) | Return On Equity (33.33) |
The market value of Avinger is measured differently than its book value, which is the value of Avinger that is recorded on the company's balance sheet. Investors also form their own opinion of Avinger's value that differs from its market value or its book value, called intrinsic value, which is Avinger's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avinger's market value can be influenced by many factors that don't directly affect Avinger's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avinger's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avinger is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avinger's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Current Deferred Revenue Analysis
Compare Avinger and related stocks such as GlucoTrack, Nexgel Inc, and Sharps Technology Current Deferred Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NXGL | 14 K | 14 K | 14 K | 14 K | 14 K | 14 K | 14 K | 14 K | 14 K | 14 K | 38 K | 54 K | 20 K | 23 K | 34.6 K |
| STSS | (804.1 K) | (804.1 K) | (804.1 K) | (804.1 K) | (804.1 K) | (804.1 K) | (804.1 K) | (804.1 K) | (804.1 K) | (804.1 K) | (804.1 K) | (804.1 K) | (804.1 K) | (723.7 K) | (759.9 K) |
| LUCY | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 42.5 K | 39.9 K |
| ANGO | 1.9 M | 3.1 M | 1.6 M | 200 K | 8.8 M | 9.4 M | 27.2 M | 32.3 M | 29.5 M | 29.5 M | (2.4 M) | 16 M | (14.8 M) | (17 M) | (16.1 M) |
| ATRC | 3.8 M | 449.2 K | 366 K | 1.5 M | 1.3 M | 912 K | 1.3 M | 634 K | 886 K | 886 K | 886 K | 886 K | 886 K | 797.4 K | 978.9 K |
| AKYA | 4.4 M | 4.4 M | 4.4 M | 4.4 M | 4.4 M | 4.4 M | 4.4 M | 4.4 M | 4.4 M | 4.4 M | 3.8 M | 4.5 M | 6.3 M | 6.7 M | 5.6 M |
| ATR | 17.2 M | 17.2 M | 42.1 M | 37.1 M | 42.6 M | 33.3 M | 44.1 M | 45.2 M | 67.8 M | 86.8 M | 87.1 M | 87 M | 80.1 M | 60.5 M | 61.8 M |
| ICUI | 2.4 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.8 M | 6.7 M | 5.6 M | 12.6 M | 30.8 M | 31.6 M | 33.2 M |
| MLSS | 86.5 K | (356.6 K) | (356.6 K) | (50 K) | (50 K) | 1 M | 1 M | 2.5 M | 521.8 K | 340.5 K | 242.6 K | 242.6 K | 242.6 K | 279 K | 495.5 K |
| PDEX | 1.1 M | 141 K | 141 K | 232 K | 594 K | 212 K | 19 K | 31 K | 215 K | 200 K | 150 K | 1 M | 453 K | 14 K | 13.3 K |
| POCI | 588.1 K | 6.4 K | 38 K | 26.2 K | 118.8 K | 180.1 K | 180.1 K | 857.8 K | 450.2 K | 417.1 K | 450.1 K | 905.1 K | 1.2 M | 1.2 M | 1.2 M |
| NEPH | (610 K) | 2.1 M | 707 K | 703 K | 70 K | 70 K | 70 K | 70 K | 396 K | 136 K | (1.2 M) | (1.2 M) | (1.2 M) | (1.1 M) | (1.1 M) |
| ZJYL | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 975.6 K | 1.7 M | 830.3 K | 829.2 K | 746.3 K | 854.1 K |
| KRMD | 132.4 K | 22.5 K | 22.5 K | 22.5 K | 22.5 K | 22.5 K | 22.5 K | 3.8 K | 3.8 K | 125.3 K | 125.3 K | 90 K | 3.4 M | 1.7 M | 1.8 M |
Avinger and related stocks such as GlucoTrack, Nexgel Inc, and Sharps Technology Current Deferred Revenue description
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.My Equities
My Current Equities and Potential Positions
| Avinger | AVGR |
Specialization | Health Care, Health Care Equipment & Services |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.84
Additional Tools for Avinger Stock Analysis
When running Avinger's price analysis, check to measure Avinger's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avinger is operating at the current time. Most of Avinger's value examination focuses on studying past and present price action to predict the probability of Avinger's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avinger's price. Additionally, you may evaluate how the addition of Avinger to your portfolios can decrease your overall portfolio volatility.